Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model

Journal of Investigative Surgery

Volumn 26, Issue 3, 2013, Pages 141-148

  Lewis, Kevin M ^a   Atlee, Holly D ^a   Mannone, Angela J ^a   Dwyer, Joseph ^a   Lin, Lawrence ^a   Goppelt, Andreas ^b   Redl, Heinz ^c  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b BAXTER INNOVATIONS GMBH   (Austria)

^c LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

Author keywords

Adjunctive hemostats; Bleeding model; Floseal; Gelatin; Hemostat; Hemostatic efficacy; Surgiflo; Thrombin

Indexed keywords

FLOSEAL; GELATIN; SURGIFLO; THROMBIN; UNCLASSIFIED DRUG; FLOSEAL MATRIX; GELATIN SPONGE; HEMOSTATIC AGENT;

ABRASION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BLOOD CLOT; COMPARATIVE EFFECTIVENESS; ERYTHROCYTE; FEMALE; HEMOSTASIS; IN VITRO STUDY; IN VIVO STUDY; LIVER INJURY; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SUPERNATANT; SWINE; ULTRASTRUCTURE; ANIMAL; BLOOD LOSS, SURGICAL; BOVINAE; COMPARATIVE STUDY; HUMAN; LIVER; PHYSICAL CHEMISTRY; PROCEDURES;

ANIMALS; BLOOD LOSS, SURGICAL; CATTLE; CHEMISTRY, PHYSICAL; FEMALE; GELATIN; GELATIN SPONGE, ABSORBABLE; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; LIVER; MICROSCOPY, ELECTRON, SCANNING; MODELS, ANIMAL; SWINE; THROMBIN;

EID: 84877702382     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.3109/08941939.2012.724519     Document Type: Article

References (26)

1. Spontnitz WD, Burks SG. Hemostats, sealants, and adhesives II: Update as well as how and when to use the components of the surgical toolbox. Clin Appl Thromb Hemost 2010;16:497-514.
2. Achneck HE, Sileshi B, Jamiolkowski RM, et al. A comprehensive review of topical hemostatic agents. Ann Surg 2010;251:217-228.
3. Boucher BA, Traub O. Achieving hemostasis in the surgical field. Pharmacotherapy 2009;29:S2-S7.
4. Oz MC, Cosgrove DM 3rd, Badduke BR, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. Ann Thorac Surg 2000;69:1376-1382. (Pubitemid 30434861)
5. Raga F, Sanz-Cortes M, Bonilla F, et al. Reducing blood loss at myomectomy with use of a gelatin-thrombin matrix hemostatic sealant. Fertil Steril 2009;92:356-360.
6. Nasso G, Piancone F, Bonifazi R, et al. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. Ann Thorac Surg 2009;88(5):1520-1526.
7. Mozet C, Prettin C, Dietze M, et al. Use of floseal and effects on wound healing and pain in adults undergoing tonsillectomy: Randomised comparison versus electrocautery. Eur ArchOtorhinolaryngol 2011Dec 30. [Epub ahead of print].
8. Chapman WC, Singla N, Genyk Y, et al. A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis. J Am Coll Surgeons 2007;205(2):256-265. (Pubitemid 47095423)
9. Doria C, Fischer CP,Wood CG, et al. Phase 3, randomized, double-blind study of plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing surgery. Curr Med Res Opin 2008;24:785-794. (Pubitemid 351428990)
10. Lawson JH, Lynn KA, Vanmatre RM, et al. Antihuman factor V antibodies after use of relatively pure bovine thrombin. Ann Thorac Surg 2005;79:1037-1038. (Pubitemid 40288779)
11. Djagny KB, Wang Z, Xu S. Gelatin: A valuable protein for food and pharmaceutical industries: Review. Crit Rev Food Sci Nutr 2001;41:481-492. (Pubitemid 32931338)
12. FLOSEAL VH S/D Instructions for Use. Deerfield, IL: Baxter Healthcare Corporation; 2005.
13. SURGIFLO Instructions for Use. Somerville,NJ: J & JWound Management; 2008.
14. EVITHROM Prescribing Information. Somerville, NJ: J & J Wound Management; 2007.
15. Adams G, Manson J Hasselblad V, et al. Acute in-vivo evaluation of bleeding with GelfoamTM plus saline and GelfoamTM Plus human thrombin using a liver square lesion model in swine. J Thromb Thrombolysis 2009;28:1-5.
16. Thornton JA. Estimation of blood loss during surgery. Ann R Coll Surg Engl 1963;33:164-174.
17. Lewis J. Pigs. In: Comparative Hemostasis in Vertebrates. Lewis J, New York: Plenum Press; 1996:286-297.
18. Hahn N, Popov-Cenic S, Dorer A. Basic values of blood coagulation parameters in pigs (Sus scrofa domesticus) [German]. Berl Munch Tierarztl Wochenschr 1996;109:23-27. (Pubitemid 126487871)
19. Bull BS, Huse WM, Brauer FS, et al. Heparin therapy during extracorporeal circulation II: The use of a dose response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg 1975;69:685-689.
20. Fitzgerald DJ, Patel A, Body SC, et al. The relationship between heparin level and activated clotting time in the adult cardiac surgery population. Perfusion 2009;24:93-96.
21. Eastoe JE. The amino acid composition of mammalian collagen and gelatin. Biochem J 1955;61:589-600.
22. Mosesson MW, DiOrio JP, M̈ uller MF, et al. Studies on the ultrastructure of fibrin lacking fibrinopeptide B (β-Fibrin). Blood 1987;69:1073-1081. (Pubitemid 17080927)
23. Weisel JW, Nagaswami C. Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. Biophys J 1992;63:111-128.
24. Oswald MW, Hunt HH, Lazarchick J. Normal range of plasma fibrinogen. Am J Med Technol 1983;49:57-59.
25. Shapiro SS, Martinez J. Human prothrombin metabolism in normal man and in hypocoagulable subjects. J Clin Invest 1969;48:1292-1298.
26. Nogueira L, Katz D, Pinochet R, et al.Comparison of gelatin matrix-thrombin sealants used during laparoscopic partial nephrectomy. BJU Int 2008;102:1670-1674.